Ausgewählte Publikationen

 Peer-reviewed research articles: ​​​​​​​

  • Wang Z*, Boretto M*, Millen R*, Natesh N*, Reckzeh ES*, Hsu C, Negrete M, Yao H, Quayle W, Heaton BE, Harding AT, Driehuis E, Beumer J, Rivera GO, van Ineveld RL, Gex D, DeVilla J, Wang D, Puschhof J, Bose S, Yeung A, Hamele C, Smith A, Bankaitis E, Xiang K, Ding S, Nelson D, Delubac D, Rios A, Abi-Hachem R, Jang D, Goldstein BJ, Glass J, Heaton NS, Hsu D, Clevers H, Shen X. Rapid tissue prototyping with micro-organospheres. Stem Cell Reports, 2022, 17, 1959-1975. (*equal contribution)
  • Ceballos J*, Schwalfenberg M*, Karageorgis G, Reckzeh ES, Sievers S, Ostermann C, Pahl A, Sellstedt M, Nowacki J, Carnero Corrales MA, Wilke J, Laraia L, Tschapalda K, Metz M, Sehr DA, Brand S, Winklhofer K, Janning P, Ziegler S, Waldmann H. Synthesis of Indomorphan Pseudo‐Natural Product Inhibitors of Glucose Transporters GLUT‐1 and ‐3. Angewandte Chemie International Edition, 2019, 58, 17016-25. (*equal contribution)
  • Reckzeh ES, Karageorgis G, Schwalfenberg M, Ceballos J, Nowacki J, Stroet MCM, Binici A, Knauer A, Brand S, Strohmann C, Ziegler S, Waldmann H. Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth. Cell Chemical Biology, 2019, 26, 1214-28.
  • Längle D, Werner TR, Wesseler F, Reckzeh ES, Schaumann N, Drowley L, Polla M, Plowright AT, Hirt MN, Eschenhagen T, Schade D. Towards second generation cardiomyogenic and anti-cardiofibrotic 1,4-dihydropyridine-class of TGFβ inhibitors. ChemMedChem, 2019, 14, 810-22.
  • Karageorgis G, Reckzeh ES, Ceballos J, Schwalfenberg M, Sievers S, Ostermann C, Pahl A, Ziegler S, Waldmann H. Chromopynones are “Pseudo Natural Product” Glucose Uptake Inhibitors Targeting Glucose Transporters GLUT-1 and -3. Nature Chemistry, 2018, 10, 1103-11.
  • Längle D, Marquardt V, Heider E, Vigante B, Duburs G, Luntena I, Flötgen D, Golz C, Strohmann C, Koch O, Schade D. Design, synthesis and 3D-QSAR studies of novel 1,4-dihydropyridines as TGFβ/Smad inhibitors, European Journal of Medicinal Chemistry, 2015, 95, 249-66.
  • Lennarz S, Heider E, Blind M, Mayer G. An Aptamer to the MAP Kinase Insert Region. ACS Chemical Biology, 2015, 10, 320-7.

Peer-reviewed reviews/Book chapters:

  • Reckzeh ES; Waldmann H. Small‐Molecule Inhibition of Glucose Transporters GLUT‐1–4. ChemBioChem, 2019, 21, 45-52.
  • Reckzeh ES, Waldmann H. Development of Glucose Transporter (GLUT) Inhibitors. European Journal of Organic Chemistry, 2020, 2020, 2321-2329.
  • Reckzeh ES, Brockmeyer A, Metz M, Waldmann H, Janning P. Target Engagement of Small Molecules: Thermal Profiling Approaches on Different Levels. Methods in Molecular Biology, Systems Chemical Biology, Ed. Ziegler S, Ed. Waldmann H, New York: Humana Press, 2019, Vol. 1888, 73-98.

Intellectual Property

  • INHIBITORS OF GLUCOSE TRANSPORTERS (GLUTs). Patent application number: 20210198269, filed Sep 2019.